a 3D rendered illustration of  the anatomical location of a breast tumor in red with extending blood vessels.

Breast cancer cells consume extracellular matrix to proliferate in low nutrient environments.

credit: istock.com/xrender

Breast cancer cells adapt to survive despite starvation

The extracellular matrix provides breast cancer cells vital amino acids that allow the cells to grow and thrive when nutrients are scarce.
Luisa Torres
| 3 min read
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Embedded in a thick wall of collagen and other extracellular matrix materials, cancer cells starve when out of reach of the blood supply that transports vital nutrients (1). In the case of breast cancer, hungry tumor cells survive by consuming the extracellular matrix surrounding them, according to a recent study published in PLOS Biology (2). 

3D illustration of a migrating breast cancer cell
Breast cancer cells consume extracellular matrix to proliferate in low nutrient environments.
credit: Keqian Nan

Lead investigator and biotechnologist Elena Rainero at the University of Sheffield studied how the extracellular matrix around cancer cells affected how cancers spread, but an interesting observation made her refocus her efforts: “I started to notice that the [cancer] cells were not just binding to the matrix, but they were also taking it inside,” she said. “If they're doing that, they must have a reason.” What she and her team found sheds light on a potential vulnerability in cancer cells and suggests possible new targets for therapeutic interventions.

Rainero’s team cultured a human breast cancer cell line and a metastatic breast cancer cell line on three different materials: collagen I, Matrigel, or plastic. Collagen I is an extracellular matrix component, while Matrigel is a protein mixture designed to mimic the extracellular matrix.  To find out how cancer cells grow under starvation, they used either nutrient-rich media or media lacking amino acids. Compared to plastic, collagen I and Matrigel supported cell growth even when nutrients were scarce, suggesting that the extracellular matrix partially rescues cell growth during nutrient deprivation. 

Rainero was surprised at the results. “I was expecting that if you removed a lot of nutrients, the cells would just die,” she said. “Apparently, cancer cells don't do that. They are really efficient at using whatever they have access to.”

When the team fluorescently labeled the collagen to track its journey inside the cancer cells, the researchers found that the ingested material accumulated inside lysosomes. There, it was degraded and used to derive essential amino acids, such as phenylalanine and tyrosine, which the cancer cells used to continue growing. “It’s always a bit surprising how fast the extracellular matrix can degrade in a tumor,” said Paolo Provenzano, a biomedical engineer at the University of Minnesota, who was not involved in the study. “This could be part of that missing puzzle; it's not all just getting degraded by classical enzymatic approaches. Instead, a lot of it is being metabolized by the cancer cells themselves.”

I was expecting that if you removed a lot of nutrients, the cells would just die. Apparently, cancer cells don't do that. They are really efficient at using whatever they have access to. 
– Elena Rainero, University of Sheffield

Rainero’s team showed that one possible mechanism through which cancer cells ingested extracellular matrix material was macropinocytosis, a form of endocytosis through which cells engulf extracellular molecules (3). Blocking or reducing expression of the macropinocytosis promoter p21-activated kinase reduced Matrigel uptake and cancer cell growth under nutrient deprivation conditions. 

In future experiments, Rainero’s team plans to inhibit amino acid metabolism in an animal cancer model to see whether tumor growth is affected. In parallel, they would also like to test whether extracellular matrix uptake occurs in other highly fibrotic cancer types such as pancreatic tumors. Provenzano added, “I suspect that a lot of [the] mechanisms [these researchers uncovered] are applicable to a broad range of breast cancer cells, and even to broader cancers, but we [need] the experiments to find out.”

References

  1. Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res  75, 544–553 (2015).
  2. Nazemi, M. et al. The extracellular matrix supports breast cancer cell growth under amino acid starvation by promoting tyrosine catabolism. PLOS Bio  22, e3002406 (2024).
  3. Kay, R. R. Macropinocytosis: Biology and mechanisms. Cells Dev  168, 203713 (2021).

About the Author

  • Luisa Torres
    Luisa is an assistant science editor at Drug Discovery News. She is a PhD in Molecular and Cellular Pharmacology from Stony Brook University who has written for NPR’s science desk.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Image Alt Text	A laboratorian wearing blue gloves places a PCR sample into a real-time PCR thermocycler, the model shown is blue and white with a large digital screen.
From primer design to sample preparation, explore comprehensive strategies to optimize PCR throughput and reproducibility.
Tackling mycoplasma contamination in biotherapeutic production
DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.
Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue